Conference Coverage

Apixaban prevails in study of 163,000 DOAC users

Publish date: April 16, 2018

 

REPORTING FROM ACC 2018

SOURCE: Deitelzweig SB. ACC 2018.

Pages

Recommended Reading

MOMENTUM 3 HeartMate 3 LVAD ‘practice changing’
MDedge Cardiology
VIDEO: Dabigatran effective for myocardial injury after noncardiac surgery
MDedge Cardiology
Barbershop intervention cuts blood pressure in black men
MDedge Cardiology
VIDEO: Patient vouchers prompt physicians to prescribe top antiplatelet drugs
MDedge Cardiology
VIDEO: PFO closure device 100% effective against future strokes
MDedge Cardiology
A refined strategy for confirming diagnosis in suspected NSTEMI
MDedge Cardiology
Statins, ACE inhibitors linked to fetal cardiac anomalies
MDedge Cardiology
Permanent His-bundle pacing superior to RV pacing
MDedge Cardiology
Cardiovascular risk in type 2 diabetes: Patients are often clueless
MDedge Cardiology
Transcatheter valves underperform for native aortic regurgitation
MDedge Cardiology

Related Articles